Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.355    0.08 (1.87%)
Bid:
4.255
Ask:
4.375
Spread: 0.12 (2.82%)
Market Cap: £209.02m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Director Shareholding

21 May 2009 07:58

RNS Number : 6285S
Seeing Machines Limited
21 May 2009
 



21 May 2009

Seeing Machines Limited

("Seeing Machines" or the "Company")

DIRECTOR & SIGNIFICANT SHAREHOLDER NOTIFICATION

The Company received advice on 20 May 2009, that on 6 May 2009, the four shareholders of JATS Technology Pty Ltd ("JATS") reorganised JATS's holding in Seeing Machines and that, as a result of that reorganisation, JATS no longer holds any shares in Seeing Machines. The shares in Seeing Machines originally held by JATS are now held directly by the founders of Seeing Machines (also the founders of JATS) including Dr Alexander Zelinsky a director of Seeing Machines.

Dr Zelinsky now holds a total of 21,448,632 Seeing Machines ordinary shares, representing 6.87% of the issued share capital.

The other three JATS shareholders now directly hold the following ordinary shares in Seeing Machines.

Holder

Shares

% of Issued Share Capital in Seeing Machines

Timothy Edwards

21,448,632

6.87%

Jochen Heinzmann

21,448,632

6.87%

Sebastien Rougeaux

21,732,464

6.96%

--- ENDS ---

Enquiries:

Seeing Machines Limited

www.seeingmachines.com 

Nick Cerneaz, CEO +61 (0) 2 6103 4700

Grant Thornton UK LLP

Fiona Owen +44 (0) 20 7383 5100

SVS Securities plc 

Ian Callaway +44 (0) 20 7638 5600

Walbrook PR Ltd

+44 (0) 20 7933 8780

Ben Knowles:  +44 (0) 7900 346 978 Ben.Knowles@walbrookpr.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSABMFTMMATMRL
Date   Source Headline
6th Jul 20069:12 amRNSDirector/PDMR Shareholding
29th Jun 20069:37 amRNSEmployee Share Option Scheme
27th Jun 200610:11 amRNSGrant of US Patent
5th Jun 200610:14 amRNSHolding(s) in Company
10th May 20069:27 amRNSHolding(s) in Company
13th Apr 20063:25 pmRNSDirector/PDMR Shareholding
13th Apr 200612:47 pmRNSNew faceLAB Camera Product
10th Apr 20069:19 amRNSMajor Industry Awards Win
15th Mar 20067:01 amRNSInterim Results
3rd Mar 20069:42 amRNSAGM Statement-Amendment
28th Feb 20069:15 amRNSAGM Statement
8th Feb 20069:25 amRNSHolding(s) in Company
31st Jan 20069:30 amRNSHolding(s) in Company
25th Jan 20069:24 amRNSHolding(s) in Company
10th Jan 20069:18 amRNS1st Glaucoma Trial Completion
20th Dec 20053:46 pmRNSIssue of Equity
6th Dec 20059:41 amRNSHolding(s) in Company
1st Dec 20058:53 amRNSAdmission to AIM-Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.